The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than age 65 and other “high-risk” individuals, while increasing the standard of evidence to approve COVID vaccines for low-risk individuals. “The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data […]